Scarlet Arceo-Orozco

Dr. Scarlet Arceo-Orozco

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2024 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
MGMarina Galicia-Moreno
Marina Galicia-Moreno
HMHugo Christian Monroy-Ramirez
Hugo Christian Monroy-Ramirez
FCFernando Caloca-Camarena
Fernando Caloca-Camarena
SAScarlet Arceo-Orozco
Scarlet Arceo-Orozco
PMPablo Muriel
Pablo Muriel
JAJuan Armendariz-Borunda
Juan Armendariz-Borunda

10 June 2024 in Cells
Verified
Journal Article
Open access
PDF file
HMHipolito Otoniel Miranda
Hipolito Otoniel Miranda
Faridi SaavedraFaridi Saavedra
Faridi Saavedra
MGMarina Galicia-Moreno
Marina Galicia-Moreno
SAScarlet Arceo-Orozco
Scarlet Arceo-Orozco
FCFernando Caloca-Camarena
Fernando Caloca-Camarena
HMHugo Christian Monroy-Ramirez
Hugo Christian Monroy-Ramirez
Hepatocellular carcinoma (HCC) development is associated with altered modifications in DNA methylation, changing transcriptional regulation. Emerging evidence indicates that DNA methyltransferase 1 (DNMT1) plays a key role in the carcinogenesis process. This study aimed to investigate how pirfenidone (PFD) modifies this pathway and the effect generated by the association between c-Myc expression and DNMT1 activation. Rats F344 were used for HCC development using 50 mg/kg of diethylnitrosamine (DEN) and 25 mg/kg of 2-Acetylaminofluorene (2-AAF). The HCC/PFD group received simultaneous doses of 300 mg/kg of PFD. All treatments lasted 12 weeks. On the other hand, HepG2 cells were used to evaluate the effects of PFD in restoring DNA methylation in the presence of the inhibitor 5-Aza. Histopathological, biochemical, immunohistochemical, and western blot analysis were carried out and our findings showed that PFD treatment reduced the amount and size of tumors along with decreased Glipican-3, β-catenin, and c-Myc expression in nuclear fractions. Also, this treatment improved lipid metabolism by modulating PPARγ and SREBP1 signaling. Interestingly, PFD augmented DNMT1 and DNMT3a protein expression, which restores global methylation, both in our in vivo and in vitro models. In conclusion, our results suggest that PFD could slow down HCC development by controlling DNA methylation.

5 April 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
HMHipolito Otoniel Miranda
Hipolito Otoniel Miranda
Faridi SaavedraFaridi Saavedra
Faridi Saavedra
MGMarina Galicia-Moreno
Marina Galicia-Moreno
SAScarlet Arceo-Orozco
Scarlet Arceo-Orozco
FCFernando Caloca-Camarena
Fernando Caloca-Camarena
HMHugo Christian Monroy-Ramirez
Hugo Christian Monroy-Ramirez
Hepatocellular carcinoma (HCC) development is associated with altered modifications in DNA methylation, changing transcriptional regulation. Emerging evidence indicates that DNA methyltransferase 1 (DNMT1) plays a key role in carcinogenesis process. This study aimed to investigate how pirfenidone (PFD) modifies this pathway and the effect generated by the association between c-Myc expression and DNMT1 activation. Rats F344 were used for HCC development using 50 mg/kg of diethylnitrosamine (DEN) and 25 mg/kg of 2-aminofluorene (2-AAF). HCC/PFD group received simultaneous doses of 300 mg/kg of PFD. All treatments lasted 12 weeks. On the other hand, HepG2 cells were used to evaluate the effects of PFD in restoring DNA methylation in the presence of the inhibitor 5-Aza. Histopathological, biochemical, immunohistochemical, and western blot analysis were carried out and our findings showed that PFD treatment reduced the amount and size of tumors along with decreased Glipican-3, β-catenin, and c-Myc expression in nuclear fractions. Also, this treatment improved lipid metabolism by modulating PPARγ and SREBP1 signaling. Interestingly, PFD augmented DNMT1 and DNMT3a protein expression, which restores global methylation, both in our in vivo and in vitro models. In conclusion, our results suggest that PFD could slow down HCC development by controlling DNA methylation.